(2010)49 MS (Serum)aCL: 18.4%, a2GPI: 10.2%, aPS: 18.4%, aPE: 32.6%Garg et al. of antiphospholipid (aPL) autoantibodies in the so-called MS-like symptoms. The reported prevalence ranged between 2% and 88%, aCL and a2GPI particularly, with predominant IgM isotype and recommending worse MS prognosis. Secondarily, an up to date overview of current … Continue reading (2010)49 MS (Serum)aCL: 18